RENAISSANCE TECHNOLOGIES LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1037389
NEW YORK, NY
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$188,300,559
-$40,668,002 QoQ
Shares Held
421,688
-16.5% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,448,283,094 across 327 Biotechnology names. VRTX ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $188,300,559 | 421,688 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $228,968,561 | 505,048 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $288,203,176 | 735,888 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $447,376,137 | 1,004,888 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $568,001,052 | 1,171,571 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $562,656,064 | 1,397,209 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $758,774,764 | 1,631,493 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $734,197,383 | 1,566,388 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $660,659,788 | 1,580,488 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $647,641,930 | 1,591,688 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $578,669,961 | 1,664,088 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $447,686,177 | 1,272,161 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $440,384,366 | 1,397,735 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $648,817,042 | 2,246,752 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $619,292,762 | 2,138,885 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $496,279,530 | 1,761,168 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $445,571,826 | 1,707,368 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $357,260,212 | 1,626,868 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $343,096,645 | 1,891,486 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $459,168,772 | 2,277,284 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $515,797,028 | 2,400,284 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $845,135,296 | 3,575,930 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,416,910,335 | 5,206,932 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,678,378,492 | 5,781,332 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,632,261,331 | 6,859,682 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||